The symptoms of the Parkinson s disease may vary from person to person. The symptoms might include the following:

Similar documents
Best Medical Treatments for Parkinson s disease

Communicating About OFF Episodes With Your Doctor

Drug Therapy of Parkinsonism. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Parkinson s Disease Foundation. PD ExpertBriefing: Managing the Motor Symptoms in PD

Treatment of Parkinson s Disease and of Spasticity. Satpal Singh Pharmacology and Toxicology 3223 JSMBS

Evaluation and Management of Parkinson s Disease in the Older Patient

Parkinson s disease. Information for patients and carers. The Leeds Teaching Hospitals NHS Trust

Understanding Parkinson s Disease Important information for you and your loved ones

Medication Management & Strategies When the levodopa honeymoon is over

Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE

Motor Fluctuations Stephen Grill, MD, PHD Parkinson s and Movement Disorders Center of Maryland and Johns Hopkins University

Optimizing Clinical Communication in Parkinson s Disease:

PARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease

parts of the gastrointenstinal tract. At the end of April 2008, it was temporarily withdrawn from the US Market because of problems related to

Moving fast or moving slow: an overview of Movement Disorders

Dr Barry Snow. Neurologist Auckland District Health Board

Parkinson s Disease Update. Presented by Joanna O Leary, MD Movement disorder neurologist Providence St. Vincent s

Chapter 8. Parkinsonism. M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University.

10th Medicine Review Course st July Prakash Kumar

Making Every Little Bit Count: Parkinson s Disease. SHP Neurobiology of Development and Disease

Medications used to treat Parkinson s disease

PARKINSON S MEDICATION

RAMBAM. Revolutionary New Treatment for Parkinson s Disease Tremors. Health Care Campus. Information Guide & Treatment Options

ASSFN Clinical Case: Bilateral STN DBS Implant for Parkinson s Disease

History Parkinson`s disease. Parkinson's disease was first formally described in 1817 by a London physician named James Parkinson

Treatment of Parkinson s Disease: Present and Future

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019

Dystonia. The condition can vary from very mild to severe. Dystonia may get worse over time or it may stay the same or get better.

Objectives. Emerging Treatments in Parkinson s s Disease. Pathology. As Parkinson s progresses it eventually affects large portions of the brain.

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology

Parkinson s Disease Current Treatment Options

Issues for Patient Discussion

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology

The Shaking Palsy of 1817

Presented by Meagan Koepnick, Josh McDonald, Abby Narayan, Jared Szabo Mentored by Dr. Doorn

Movement Disorders. Eric Kraus, MD! Neurology!

Parkinsons Disease update. Sindhu R Srivatsal MD MPH Virginia Mason Medical Center

2-The age at onset of PD is variable, usually between 50 and 80 years, with a mean onset of 55 years (1).

DVD. Inside. Featuring Michael J. Fox

Parkinson s Disease. Patients will ask you. 8/14/2015. Objectives

Parkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O.

Re-Submission. Scottish Medicines Consortium. rasagiline 1mg tablet (Azilect ) (No. 255/06) Lundbeck Ltd / Teva Pharmaceuticals Ltd.

Parkinson's Disease and how you can make a difference with medication

Parkinson s disease Therapeutic strategies. Surat Tanprawate, MD Division of Neurology University of Chiang Mai

PD: Key Treatment Considerations

Parkinson s Disease Medications: Professionals Edition

Let s Look at Parkinson s (PD) Sheena Morgan Parkinson s Disease Nurse Specialist Isle of Wight NHS Trust November 2016

SNOEZELEN FOR THE PEOPLE WITH PARKINSON'S DISEASE

Cardinal Features of Parkinson s. Management of Parkinson s Disease. Drug Induced Parkinson s. Other Parkinson s Symptoms.

What is the best medical therapy for early Parkinson's disease? Medications Commonly Used for Parkinson's Disease

Parkinson s Disease. Sirilak yimcharoen

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

The Role of Pharmacists in Treating & Managing Parkinson s Disease Author: Mary Jo Carden, RPh, JD Principal, Carden Associates

Pilates as a modality to increase movement and improve quality of life for those suffering from Parkinson s Disease

Prior Authorization with Quantity Limit Program Summary

9/26/18. Objectives. Disclosures. Parkinson s Disease Update Clinical and Operational Considerations

Margo J Nell Dept Pharmacology

475 GERIATRIC PSYCHOPHARMACOLOGY (p.1)

Drugs used in Parkinsonism

THE ART OF MEDICATION MANAGEMENT IN PARKINSON S DISEASE

European Commission approves ONGENTYS (opicapone) a novel treatment for Parkinson s disease patients with motor fluctuations

Parkinson's Disease KP Update

UNDERSTANDING PARKINSON S AND THE POWER OF INTENT. Samantha Elandary, MA, CCC-SLP Founder & Chief Executive Officer Parkinson Voice Project

Parkinson s Disease. Prevalence. Mark S. Baron, M.D. Cardinal Features. Clinical Characteristics. Not Just a Movement Disorder

Appendix 2: Admissions checklists for people with Parkinson s

Form B3L: UPDRS Part III Motor Examination 1

Data Collection Worksheets

ID # COMPLETED: YES.. 1 DATE NO... 5 NEUROLOGICAL EXAM

CE Prn. Pharmacy Continuing Education from WF Professional Associates ABOUT WFPA LESSONS TOPICS ORDER CONTACT PHARMACY EXAM REVIEWS

Parkinson disease What is Parkinson's disease? What causes the disease?

8/28/2017. Behind the Scenes of Parkinson s Disease

CONTRIBUTORS The American Academy of Neurology Institute.

An Overview of Parkinson s Medication used in Multiple System Atrophy

Drugs Affecting the Central Nervous System

Key Concepts and Issues in Parkinson s Disease in 2016

05-Nov-15. Impact of Parkinson s Disease in Australia. The Nature of Parkinson s disease 21st Century

Movement Disorders: A Brief Overview

Parkinson s Disease and Its Treatment

Parkinson s Disease. Gillian Sare

Parkinson s Disease and Treatment Options for the Younger Adult

Parkinson s Disease Update

Parkinson s Disease and Treatment Options for the Younger Adult

ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE

PD ExpertBriefings: Parkinson s Medications: Today and Tomorrow Led By: Cynthia L. Comella, M.D., F.A.A.N.

An Overview of Parkinson s Medication used in Multiple System Atrophy

Neurodegenerative Disease. April 12, Cunningham. Department of Neurosciences

2/20/18. History of Parkinson s. What is happening in the brain? DOPAMINE! Epidemiology. Parkinson s Disease. It s much more than tremor

XADAGO (safinamide) oral tablet

Scottish Medicines Consortium

Faculty. Joseph Friedman, MD

PARKINSON S SYMPTOM TRACKER

PARKINSON S PRIMER. Dr. Kathryn Giles MD, MSc, FRCPC Cambridge, Ontario, Canada

Drug Management of Parkinsonism. By Prof. Mohammad Saleh M. Hassan PhD. (Pharma); MSc. (Ped.); MHPE (Ed.)

Drugs for Parkinson s Disease

DRUGS THAT ACT IN THE CNS

U n i f i e d P a r k i n s o n s D i s e a s e R a t i n g S c a l e ( U P D R S )

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Transcription:

1

PARKINSON S DISEASE Parkinson's disease is a long term disease related to the central nervous system that mainly affects the motor system, resulting in the loss of dopamine, which helps in producing brain cells. Parkinson's disease is a progressive disorder of the nervous system that affects the regular movement of the body. It develops gradually, sometimes starting with a barely noticeable tremor in one hand. A tremor might be the most well-known sign of Parkinson's disease but apart from that the disorder also causes stiffness or slowing of regular movement. 2

Symptoms The symptoms of the Parkinson s disease may vary from person to person. The symptoms might include the following: Tremor - A tremor or shaking of a body part, usually seen in a limb, often being a hand or fingers. The major symptom of Parkinson's disease is the sudden tremor of your hand when it is relaxed (at rest). Slowed movement (bradykinesia): Over the time, this disease may reduce the person s ability to move and slow his or her movement, making simple tasks of daily life difficult and timeconsuming. Your steps may seem to become shorter when you are in motion, or at times you may find it difficult to get out of a chair. Also, you may have to drag your feet while walking, making it more difficult to walk. Rigid muscles: Stiffness of muscles may occur in any part of the body. The stiff muscles can limit your range of motion and might cause you extreme pain. Impaired posture and balance: The posture of the affected person may be stooped, or he or she might face balance related problems, which is a result of Parkinson's disease. Loss of automatic movements: While you are affected with parkinson's disease, you may have a decreased ability to perform the unconscious movements, for e.g., blinking, smiling or swinging your arms when you walk. 3

Changes in speech: One may experience speech problems as a result of Parkinson's disease. One might speak softly, quickly, slur or hesitate before talking. Changes in writing: The affected person may find difficulty while writing and the writing may appear small. Causes The causes of Parkinson s disease is unknown, but the below factors can play an important role. Genes: Few specific genetic mutations may cause Parkinson's disease, but these are quite uncommon except in some rare cases, where most of the family members are affected with Parkinson's disease. Environmental triggers: Exposure to certain toxins or environmental factors increases the risk of this particular disease later, but the risk is relatively small. Diagnosis There is no specific test for the diagnosis of this particular disease. However, few neurological and physical test may be done along with some blood tests, to find out the conditions that are possibly causing the symptoms. 4

Treatment There is no drug to cure Parkinson s disease, but medications can help to control the symptoms. Doctor may also recommend a few changes in the lifestyle, e.g., the habit of regular aerobic exercise. In some cases, the physical therapy which focuses on the balance and stretching is also important. A speech-language pathologist may help you in improving your speech problems. Medications: Medications helps to manage problems with walking, movement and tremor. These medications might substitute for dopamine, a specific signaling chemical (neurotransmitter) in your brain. Carbidopa-levodopa: Levodopa can be the most effective medication for Parkinson's disease. It is a natural chemical that passes into your brain and is converted to dopamine. If levodopa is combined with carbidopa (Rytary, Sinemet), it protects the levodopa from the premature conversion to dopamine, which prevents or lessens the side effects such as nausea. Dopamine agonists - The dopamine agonists don't change into dopamine. Instead, they mimic dopamine effects in your brain. Dopamine agonists include pramipexole, ropinirole and rotigotine. 5

MAO-B inhibitors: These medications include selegiline and rasagiline. They help in preventing the breakdown of brain dopamine by inhibiting the brain enzyme monoamine oxidase B (MAO-B). This enzyme metabolizes brain dopamine. Catechol-O-methyltransferase (COMT) inhibitors: The primary medication from this class is Entacapone. This medication mildly effects the levodopa therapy by blocking an enzyme that breaks down dopamine. Anticholinergics: These medications are used for many years to control the tremor associated with Parkinson's disease. Several anticholinergic medications are available, including benztropine or trihexyphenidyl. Surgery Deep brain stimulation: In deep brain stimulation or DBS, the surgeons implant electrodes into a particular part of your brain. The electrodes are connected to a generator which is implanted in your chest near the collarbone that sends electrical pulses to your brain and may reduce your Parkinson's disease symptoms. 6

Thank You For more health and wellness articles visit www.sastasundar.com 7